A 12-week Comparative Prospective Open-label Randomized Controlled Study in Depression Patients Treated with Vilazodone and Escitalopram in a Tertiary Care Hospital in North India

BACKGROUND: Depression is a leading cause of morbidity in modern world and introduction of selective serotonin reuptake inhibitors (SSRIs) was a revolution for treating depression. However, sexual dysfunction and weight gain always remained an issue for patients leading to discontinuation of treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Bathla, Manish, Anjum, Shazia, Singh, Manpreet, Panchal, Saminder, Singh, Gurvinder Pal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795684/
https://www.ncbi.nlm.nih.gov/pubmed/29403135
http://dx.doi.org/10.4103/IJPSYM.IJPSYM_368_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795684/
https://www.ncbi.nlm.nih.gov/pubmed/29403135
http://dx.doi.org/10.4103/IJPSYM.IJPSYM_368_17

Ejemplares similares